Skip to content
Equity

Unrealized Losses on Investments (Before Tax)

Medtronic Unrealized Losses on Investments (Before Tax) decreased by 3.5% to $55M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 59.0%, from $134M to $55M. Over 5 years (FY 2020 to FY 2025), Unrealized Losses on Investments (Before Tax) shows an upward trend with a 12.9% CAGR.

Analysis

StatementBalance Sheet Statement
SectionEquity
First reportedQ1 2018
Last reportedQ4 2025Feb 24, 2026
Metric ID: unrealized_losses_on_investments

Historical Data

19 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25
Value$35M$49M$79M$245M$269M$460M$338M$305M$326M$347M$228M$252M$174M$138M$134M$100M$84M$57M$55M
QoQ Change+40.0%+61.2%+210.1%+9.8%+71.0%-26.5%-9.8%+6.9%+6.4%-34.3%+10.5%-31.0%-20.7%-2.9%-25.4%-16.0%-32.1%-3.5%
YoY Change+668.6%+838.8%+327.8%+24.5%+21.2%-24.6%-32.5%-17.4%-46.6%-60.2%-41.2%-60.3%-51.7%-58.7%-59.0%
Range$35M$460M
CAGR+10.6%
Avg YoY Growth+95.2%
Median YoY Growth-32.5%
Current Streak7 quarters decline

Unrealized Losses on Investments (Before Tax) at Other Companies

Frequently Asked Questions

What is Medtronic's unrealized losses on investments (before tax)?
Medtronic (MDT) reported unrealized losses on investments (before tax) of $55M in Q4 2025.
How has Medtronic's unrealized losses on investments (before tax) changed year-over-year?
Medtronic's unrealized losses on investments (before tax) decreased by 59.0% year-over-year, from $134M to $55M.
What is the long-term trend for Medtronic's unrealized losses on investments (before tax)?
Over 5 years (2020 to 2025), Medtronic's unrealized losses on investments (before tax) has grown at a 12.9% compound annual growth rate (CAGR), from $30M to $55M.